Balto, Real-time AI Call-Guidance Software, raises additional $3 million in Seed funding

Balto, the world’s first artificial intelligence software for real-time call guidance and coaching, announced today that it closed a $3 million seed financing round.

ST. LOUIS, Sept. 26, 2019 /PRNewswire/ — Participating in the round are OCA Ventures (co-lead), Stage Venture Partners (co-lead), Jump Capital, Cultivation Capital, SaaS Ventures, TIA Ventures, and Sandalphon Capital. This round of funding will be used to scale the organization’s sales and marketing capabilities, expand headcount, and make major investments in applying A.I. to help sales teams make their sales messaging more effective.

CEO Marc Bernstein, COO Chris Kontes, and CTO Davidson Girard founded Balto in January 2017 to address the multibillion-dollar need to optimize revenue opportunities and eliminate costly mistakes on sales calls. Since inception, Balto has guided almost 10 million phone calls and has consistently doubled its customer base every five months.

Balto uses artificial intelligence to analyze both sides of the conversation and instantly deliver critical information to sales representatives before they lose valuable sales calls. Balto is fully customizable and is the only call guidance software solution that can provide real-time feedback without storing any transcripts or call recordings. Balto has attracted customers across all industries, from 2-person sales teams to fast-growing publicly traded companies in financial services, healthcare, home improvement, pharmaceuticals, utilities, retail, insurance, collections, and enterprise technology.

“We are thrilled to be leading a second round in Balto Software just 13 months after our first,” says Alex Rubalcava of Stage Venture Partners. “Balto has built a world-leading real-time call guidance product that brings unprecedented AI-powered coaching to every agent on the call center floor. Balto also empowers sales managers with speech analytics and live data so they know, for the first time, how well their teams are selling in the moment.”

“The A.I. is powerful, the rep coaching is effective and the results are measurable. Balto has built a category-leading product and developed sales and marketing functions far ahead of typical seed stage companies,” says Tamim Abdul Majid of OCA Ventures.

With this newest round of funding, Balto is thrilled to continue expanding its St. Louis-based team and serving its customers nationwide.

About Balto

Balto is the #1 AI technology for real-time call guidance and coaching. Balto’s software solution listens to both sides of a call and instantly delivers critical information and feedback to sales representatives before they lose valuable sales calls. Balto is fully customizable and current customers include sales teams, contact centers, and customer service groups in sectors ranging from debt collections to healthcare and home improvement.

For more information, contact:
For press inquiries, contact:


Related Links

SpotHero Scoops Up $50M

By Jim Dallke -August 22, 2019

Chicago parking app SpotHero landed $50 million in new funding as it looks to help more people find on-demand parking.

The round was led by Macquarie Capital, an Australia-based investment bank. Other backers in the round include Insight Venture Partners, Global Founders Capital, OCA Ventures and AutoTech Ventures.

SpotHero has now raised $118 million since it launched in 2011. It’s the latest Chicago startup to crack the VC funding century mark, joining AMP AmericasFourkitesSprout Social, and G2 Crowd, who’ve all crossed over $100 million in total capital raised within the last 12 months.

SpotHero now offers drivers access to 7,000 off-street parking locations in 300 cities, making it the largest marketplace to find a parking spot in North America, the company said.

The startup said that its all-time sales have now reached more than $500 million, and it’s on pace to reach $1 billion in all-time transactions by 2020.

“By standardizing the way parking is bought and sold, we are introducing the same visibility into parking inventory that people expect from the airline or hospitality industries,” Mark Lawrence, CEO and co-founder of SpotHero, said in a statement.

Earlier this year, SpotHero announced SpotHero for Fleets, a parking-as-a-service solution for the car-sharing economy that helps fleet providers like Car2Go find parking—while also preparing for the industry’s eventual transition to autonomous vehicles. It launched SpotHero for Business in 2017, which helps employers manage parking spend. The startup said earlier this year that it has 600 enterprise clients on the platform.

mPulse Mobile ranks on 100+ artificial intelligence companies to know in healthcare | 2019

Jenna Bloom and Laura Dyrda – Friday, July 19th, 2019

Artificial intelligence and machine learning are quickly becoming an integral part of healthcare delivery.

Both on the clinical care and operational side of healthcare organizations, AI has is powering technology that keeps patients safe and improves efficiency for the revenue cycle, supply chain and more.

Here are 100-plus companies in the healthcare space using artificial intelligence.

To add a company to this list, contact Laura Dyrda at

Aidoc (Tel Aviv, Israel). Aidoc provides radiologists with artificial intelligence (AI) for clinical settings. Their FDA cleared solution detects time-sensitive pathologies and prioritizes them in the radiology workflow, allowing leading health systems to improve outcomes and patient safety.

AiCure (New York City). AiCure is an AI and advanced data analytics company that uses video, audio and behavioral data to better understand the connection between patients, disease and treatment. It allows physicians to have access to clinical and patient insights.

Aiva Health (Los Angeles). Aiva Health developed Aiva, the first voice-powered care assistant. The software understands requests and instantly connects patients with the correct physician for communication.

Apixio (San Mateo, Calif.). Apixio’s AI platform transforms disparate text and coded data into actionable knowledge and health insights for better decision making.

Arterys (San Francisco). Arterys is a leader in intelligent, cloud-based medical imaging software. It created the first medical imaging cloud platform powered by artificial intelligence.

AtomWise (San Francisco). AtomWise developed AtomNet, a drug-designing technology based on convolutional neural networks. It aims to help its partners deliver better medicines faster.

Ayasdi (Menlo Park, Calif.). Ayasdi designs applications and an enterprise-grade software platform that allows healthcare organizations to analyze and build predictive models that solve complex challenges in the industry by using big data or highly dimensional data sets.

Babylon Health (London). Babylon is a digital healthcare provider that aims to create an internationally accessible and affordable health system for all. (New York City). Belong’s end-to-end patient engagement platform (PEP) for payers, providers, pharma and advocacy groups utilizes AI and machine learning to deliver hyper-personalized patient experiences. Additionally, the Belong “Beating Cancer Together” app unites 200,000 global cancer patients, caregivers and healthcare professionals, delivering AI-powered personalized news, peer support, direct access to doctors, clinical trial matching services and document management tools.

Bigfoot Biomedical (Milpitas, Calif.). Bigfoot Biomedical is the creator of the automated insulin delivery system. The company works to improve the health and safety of those suffering from Type 1 diabetes through the creation of smart devices.

BioXcel Therapeutics (New Haven, Conn.). BioXcel Therapeutics is a clinical stage biopharmaceutical company that uses AI to create medicines in neuroscience and immuno-oncology.

Bot M.D. (Singapore). Bot M.D. is an AI application that acts like an assistant. It can answer clinical questions, transcribe dictated case notes and automatically organize images and files.

Buoy Health (Boston). Buoy is an artificial intelligence computational platform that allows ill users to understand their symptoms, get answers and form a treatment plan through chatting.

Butterfly Network (Guilford, Conn.). Butterfly Network is a digital health company that works to make medical imaging universally accessible and affordable. The company created Butterfly iQ, the world’s first handheld whole-body ultrasound system that connects to a smartphone.

Cardinal Analytx Solutions (Palo Alto, Calif.). Cardinal Analytx Solutions, an artificial intelligence-enabled health insights company, helps organizations predict and identify future health risks, improve patient outcomes and costs and develop an action plan for reducing such determinants.

Cathworks (Aliso Viejo, Calif.). Cathworks delivers an image-based approach for assessing FFR (functional flow reserve) in the cath lab using data from standard angiograms. Cathworks’ CE marked and FDA approved solution creates a personalized 3D model of each patient’s arteries and uses algorithms to simulate blood flow and assess the impact of arterial blockages without the use of a pressure wire.

Change Healthcare (Nashville, Tenn.). Change Healthcare is a healthcare technology company delivering software, analytics and solutions to improve the healthcare system. The company includes artificial intelligence in several products, most recently unveiling Claims Lifecycle Artificial Intelligence in February.

Clarify Health Solutions (San Francisco). Clarify Health Solutions uses technology and an analytics platform to solve many of the complex challenges facing healthcare professionals and to personalize and optimize patient care journeys.

Cloud Pharmaceuticals (Research Triangle Park, N.C.). Cloud Pharmaceuticals uses new, innovative cloud computing technology to accelerate the process of designing drugs and drug candidates. The process is called Quantum Molecular Design.

CloudMedx (Palo Alto, Calif.). CloudMedx uses AI, data-driven models to improve clinical insights, revenue cycle management and patient care.

Curemetrix (La Jolla, Calif.). Curemetrix is working toward developing the next generation of medical image analysis technology. In particular, it uses a patent-pending algorithm to create more precise and advanced tools for mammography.

Cyrcadia Health (Reno, Nev.). Cyrcadia Health designed a wearable, intelligent breast monitor device that uses breast patches that identify circadian patterns within breast cells to keep physicians aware of patients’ breast health.

Day Zero Diagnostics (Boston). Day Zero Diagnostics is develoipng a rapid in-vitro diagnostic for identification of bacterial pathogens and antibiotic susceptibility profiles. The company combines genomic next generation sequencing (NGS) and machine learning to combat antimicrobial resistant infections, enabling physicians to switch from harmful and costly broad-spectrum antibiotics to targeted antibiotic therapy within hours instead of days.

Deep Genomics (Toronto, Canada). Deep Genomics uses their AI platform to rapidly direct them to the best drug candidates. The company is designing new ways of detecting and treating disease using biologically accurate AI technology.

Deep Lens (Columbus, Ohio). Deep Lens manages the largest digital pathology cloud platform that allows pathology groups to collaborate on cancer research.

Desktop Genetics (Cambridge, Mass.). Desktop Genetics works to discover and treat the root genetic causes of human disease and has emerged as a leader in genome editing technology. Its core technology is DESKGEN AI, which powers DESKGEN CRISPR that helps with drug discovery and functional genomics.

Digital Reasoning (Nashville, Tenn.). In healthcare, Digital Reasoning deploys AI-powered care management software within health systems to augment the care team and accelerate the entire care process, delivering a positive impact on clinical, financial and operational outcomes.

DreaMed Diabetes (Petah Tikva, Israel). DreaMed Diabetes’ management platform uses unique cloud-based AI technology to provide patients with insulin treatment insights and plans. It simplifies the complexity of diabetes data.

Enlitic (San Francisco). Enlitic connects human and artificial intelligence and data to advance medical diagnostics. The company collects and analyzes data and designs medical software that allows physicians to diagnosis faster and more accurately.

FDNA (Boston). FDNA uses artificial intelligence to analyze genetic, phenotypic information databases to detect physiological patterns that reveal disease-causing genetic variations.

Flatiron Health (New York City). Flatiron Health developed OncoCloud, a shared technology platform that connects community, oncologists, academics, hospitals, life science researchers and regulators to better treat cancer.

Futurus Group (Irvine, Calif.). Futurus Group is the first AI machine-learning company to develop an algorithm to predict gratitude within a hospital’s grateful-patient program. Futurus Group’s patent-pending G2G (Gratitude to Give) algorithm leverages data within a hospitals EMR, donor CRM and patient satisfaction data to predict individuals most likely to make a gift to a hospital or medical center. (Palo Alto, Calif.). developed an application that collects personal health data that can be used by medical researchers to accelerate discovery or as health insights for the user.

Ezra (New York City). Ezra designed full-body, MRI technology that detects up to 13 cancers in women and 11 in men.

FitGenie (Atlanta). FitGenie is an AI, nutrition application that aids people by providing tools and instructions for maintaining and optimizing nutritional health. More specifically, it is a smart calorie counter that tells users what to eat to reach their goals.

Freenome (South San Francisco, Calif.). Freenome seeks to transform the way medicine is practiced by using artificial intelligence, biology and computer science to detect disease earlier and more accurately.

Gauss Surgical (Menlo Park, Calif.). Gauss Surgical is the leading developer of an AI-enabled platform for real time monitoring of surgical blood loss.

Genoox (Palo Alto, Calif.). Genoox delivers a data-driven, cloud-based solution that unlocks the value of genomics. The company’s adaptive AI solution leverages proprietary datasets that transform raw genetic information into actionable real world evidence enabling customers to develop customized clinical NGS genetic applications with accelerated turnaround time delivering insights within hours instead of weeks. (San Francisco). provides clients with an on-demand coach, therapist and psychiatrist for instant care.

H1 (New York City). H1 is a live data insights platform for diseases, driven by machine learning. The platform is able to find data from any public clinical and scholarly database in the world, drawing on curated data from “hundreds of thousands” of website profiles and conference presentations. H1’s tools search across more than 250,000 academic researchers, 250,000 clinical trials, 50 million journal articles, and 750,000 clinicians and physicians. (Mountain View, Calif.). is the creator of the leading open source data science and machine learning platform, Driverless AI.

Healint (Singapore). Healint designed the leading migraine application, Migraine Buddy, which tracks users’ migraines, understands triggers and shares migraine history with physicians to better treat and efficiently improve the invisible pain.

Health at Scale (San Jose, Calif.). Health at Scale uses machine intelligence to deliver precision care by matching patients to the right treatments by the right providers at the right times.

Health Fidelity (San Mateo, Calif.). Health Fidelity uses technology and expertise to allow organizations participating in Medicare Advantage, ACA commercial, Managed Medicaid or Medicare ACO programs to provide risk adjustment solutions.

HealthReveal (New York City). HealthReveal uses artificial intelligence to reduce costs, improve outcomes and quality of life and save lives for the chronically ill.

IBM Watson Health (Chicago). IBM Watson Health aims to solve health challenges using data, analytics and AI. The company works with more than 300 hospitals and healthcare organizations to make decision based on data.

iCAD (Nashua, N.H.). iCAD is a global medical technology leader that uses artificial intelligence to provide cancer detection and therapy solutions so physicians can detect cancers earlier.

IDx (Coralville, Iowa). IDx developed the first automated diabetic retinopathy diagnostic AI machine called IDx-DR. The company works to transform healthcare through the automation of medical diagnosis and treatment.

Imperativ (New York City). Imperativ’s Enterprise Intelligence Platform delivers digital twin modules and associated applications that connect and optimize the internet of medical things for decision making.

Innovaccer (San Francisco). Innovaccer is a healthcare data activation company that works to improve care delivery by making full use of all the data the healthcare industry has collected.

Inovalon (Bowie, Md.). Inovalon is a healthcare technology company designing platforms to empower data-driven healthcare. The company’s leading ONE Platform allows clients and partners to use datasets, analytics and technologies to improve healthcare outcomes and economics.

Insightin Health (Baltimore). Insightin Health created the only existing AI platform for members’ complete lifecycle. The platform delivers a personalized experience using health data and social determinants to identify the best ways to communicate with others.

Inspiren (New York City). Inspiren is the inventor of iN, an automated patient safety monitoring device that aims to reduce injuries and deaths by ensuring patients receive proper care.

Jvion (Johns Creek, Ga.). Jvion uses prescriptive analytics to prevent harm and lower costs. Its technology identifies patients on a risk trajectory, determines if that trajectory can be changed and identifies possible interventions, if applicable.

K Health (New York City). K Health developed K, the first personalized healthcare application that allows patients to check their symptoms, explore treatment options and chat with doctors for free.

KenSci (Seattle). KenSci uses AI to help providers and payers intervene earlier and at lower costs. Its platform helps uncover clinical, operational and financial risks by aggregating data.

Lunit (Seoul, South Korea). Lunit is a medical AI software company that uses cutting-edge technology and medical data to discover, design and develop imaging biomarkers.

Massive Bio (New York City). Massive Bio is a marketplace that connects oncology patients and their treating oncologist to the cutting edge advanced care options and clinical trials while enabling enterprises to get access to patients and their information to enhance oncology research. Massive Bio resides at the intersection of patient acquisition, artificial intelligence based scalable pre-screening, operationalization support and real world data to connect patients to oncology trials. 

MaxQ AI (Andover, Mass.). MaxQ AI is a leader in medical diagnostic AI. The company’s software uses artificial intelligence to interpret medical images to help physicians make more accurate and faster diagnoses of strokes, brain trauma and other conditions.

Medable (Palo Alto, Calif.). Medable is pioneering a new category of life science technologies that replace the stagnant and siloed data of traditional ePRO, eCOA, EDC, and eSource with an intelligent and unified end-to-end (E2E) platform for clinical trial execution. Medable’s E2E platform connects patients, sites, CRO’s and sponsors to work together as a connected and empowered team in clinical research, to bring new medicines to patients faster.

Medalogix (Nashville, Tenn.). Medalogix is a pioneer data science company focusing on home health and hospice. Its technology identifies risk, creates action, improves patient outcomes and delivers ROI.

Medasense (Israel). Medasense’s NOL Index is the first objective pain assessment index for accurate and personalized pain care.

MedAware (Israel). MedAware’s technology uses big data analytics and machine learning algorithms to analyze electronic medical records to learn how physicians treat patients to identify and eliminate a wide range of medication errors.

Medial EarlySign (Hod Hasharon, Israel). Medial EarlySign helps healthcare systems with their early detection and prevention of high-burden diseases. The company’s machine learning-based software finds subtle, early signs of elevated patient risk trajectories in routine, existing EHR and lab data.

MedWhat (San Francisco). MedWhat is a medical artificial intelligence company that is building an algorithmic architecture to achieve human-level intelligence in medicine. The software acts as a personal assistant by answering medical and health questions for consumers and doctors. (San Jose, Calif.). Mendel is a network of research sites powered by AI and clinical insights that works to unlock the full potential of clinical data relevant to cancer research.

mPulse Mobile (Encino, Calif.). mPulse is the leading developer of conversational AI solutions for the healthcare industry. It improves health outcomes and business efficiencies.

Myia Labs (San Francisco). Myia Labs is an intelligent health monitoring platform that helps prevent illness, manages chronic conditions and redefines quality of life by transforming real-world data into clinical, objective insights.

NarrativeDx (Austin, Texas). NarrativeDx uses AI to identify insights from patient hospital experience feedback to increase ranking, scores and referrals and reduce nurse turnover.

NextHealth Technologies (Denver). NextHealth’s AI and machine learning analytics platform combines data-driven decision making into workflow to improve healthcare affordability.

Notable (San Mateo, Calif.). Notable uses wearable technology, voice interface, friction free integrations and artificial intelligence to make patient-clinician interaction more efficient and effective.

NuMedii (San Mateo, Calif.). NuMedii is a leader of using big data, AI and biology to accelerate the discovery of precision therapies and drugs.

Numerate (San Bruno, Calif.). Numerate uses AI technology to simplify the complex process of molecular drug design.

Olive (Colorado Springs, Colo.). Olive is a custom software solution provider that offers a list of services that empowers organizational growth by building their technology engines.

Pager (New York City). Pager simplifies the healthcare experience by connecting patients and their care team in a single AI chat to make smarter and faster health decisions.

Paige.AI (Franklin D. Roosevelt Island, N.Y.). Paige.AI uses artificial intelligence to help pathologists work more efficiently, researchers discover new insights and clinicians improve patient care.

PathAI (Boston). PathAI develops technology that helps pathologists make rapid and accurate diagnoses. It also helps patients receive the most personalized, effective treatment for their condition.

Pathway Genomics (San Diego). Pathway Genomics provides physicians and their patients with actionable and accurate precision healthcare information to improve and maintain health and wellness.

Pearl (Columbus, Ohio). Pearl uses care management services and remote health, home monitoring technology to effectively and efficiently provide wider quality access. The company helps government agencies and commercial enterprises provide a wider access of quality healthcare to all populations.

Picwell (Philadelphia). Picwell’s technology simplifies the complex benefits decision-making process by matching users with their optimal plan.

Potrero Medical (Hayward, Calif.). Potrero Medical is a predictive health company that develops smart sensors and artificial intelligence. It is currently creating a predictive health platform to help physicians better predict adverse outcomes in critical care settings.

Prognos (New York City). Prognos maintains the largest sources of lab data across 50 disease areas with records for 200 million patients.

Proscia (Philadelphia). Proscia developed Concentriq, a digital pathology platform, and AI applications that have and continue to transform the practice of pathology by focusing on personalized, data-centric medicine.

Pure Storage (Mountain View, Calif.). Pure Storage, a leading data storage company, allows its clients to efficiently deliver real-time secure data to perform operations.

QuartzClinical (Chicago). QuartzClinilcal uses advanced technology to help users achieve better outcomes through more cost-efficient and effective measures. The software uses predictive models, financial insights and personal health records to help make better clinical decisions

Qventus (Mountain View, Calif.). Qventus uses artificial intelligence and machine learning to help healthcare organizations operate more efficiently and simply.

Recondo Technology (Denver). Recondo Technology’s revenue cycle content engine intelligently automates the healthcare revenue cycle using a combination of AI technologies that include robotic process automation, clinical language processing and machine learning models based on extensive domain expertise. Among the first companies to develop AI specifically for the healthcare revenue cycle, today Recondo’s accurate, automated and actionable solutions replace expensive manual communication between payers and providers with high volume, high speed transactions in over 900 organizations.

Renalytix AI (Cardiff, United Kingdom). Renalytix AI develops artificial intelligent clinical diagnostic solutions for kidney disease. Its products improve risk assessment, clinical care and patient stratification for drug clinical trials.

ReveKnow (Lake Forest, Calif.). ReveKnow provides low-cost access to advanced machine learning algorithms that can predict a patient’s propensity to pay a bill, calculate percentage to FPL for presumptive charity, or estimate the probability that a denied account can be overturned. All of these services are designed for smaller budget-conscious hospitals to optimize their limited resources and focus first on the accounts most likely to produce a positive outcome.

Risalto Health (New York City). Risalto Health’s AI platform uses big data to identify the best providers and advice on care for patients suffering from neck, knee and hip pain problems.

Robin Healthcare (Berkeley, Calif.). Robin Healthcare created Robin, an AI device that completes all clinical documentation and billable notes for physicians during appointments with patients.

Sensely (San Francisco). Sensely is an application that intelligently connects insurance plan members with health related advice and resources and insurance services.

Sentrian (Australia). Sentrian provides organizations’ employees with the tools, skills and support to work technology. It provides the pieces for companies to build their IT system and grow their business.

SkinIO (Chicago). SkinIO is a mobile application that takes approximately five minutes to perform a full-body scan of moles or other concerning skin marks by using camera taken images. It also allows physicians to track any changes in skin condition.

SkinVision (Amsterdam). SkinVision’s combined technology and knowledge helps users check their skin for signs of skin cancer with instant results on a smartphone.

SmartPlate (Philadelphia). SmartPlate is the first intelligent wellbeing platform that uses advanced photo recognition and AI technology to identify, weigh and analyze anything users eat. The device instantly tracks calories by using a mobile application and a smart plate.

Sopris Health (Denver). Sopris Health developed the first AI medical scribe technology that works to improve clinical efficiency and decrease administrative burden.

Spring Health (New York City). Spring Health created and implements Precision Mental Healthcare, a method of accurately predicting the right treatment and accelerating mental health recovery by using the same scientific principles behind precision medicine.

Suki (Redwood City, Calif.). Suki is an artificial intelligence-powered, voice-enabled digital assistant for doctors that enables physicians to focus on patient care by reducing administrative burden. It’s personalized for each doctor, gets smarter with ongoing use, and can be scaled rapidly and inexpensively. 

Tagnos (Aliso Viejo, Calif.). Tagnos developed a clinical logistics automation solution to orchestrate care delivery. The application predicts and optimizes patient flow.

Touchkin (Bengaluru, India). Touchkin’s Wysa is a pioneer AI-driven empathetic, compassionate conversation coach that instantly helps users improve their mental health.

TrialJectory (New York City). TrialJectory is an AI-based trial matching platform that uses cancer patients’ self-reported medical records to facilitate clinical trial search, matching and enrollment.

twoXAR (Mountain View, Calif.). twoXAR is an artificial intelligence-driven drug discovery company that uses its platforms to identify promising drug candidates, de-risk opportunities and progress drug candidates to clinics.

Univfy (Los Altos, Calif.). Univfy is dedicated to helping women and couples wanting to have a baby increase IVF access, success and affordability through an AI platform. The software allows physicians to form accurate, personalized IVF treatment prediction plans.

Verge Genomics (South San Francisco). Verge Genomics uses advanced machine learning, computational genomics and new insights into neuroscience to reduce the time and cost of drug discovery for patients suffering from neurodegenerative disease.

VIDA Diagnostics (Coralville, Iowa). VIDA Diagnostics provides clients with software and services that can aid in early detection, evaluation and treatment planning of lung disease.

VisiQuate (Santa Rosa, Calif.). VisiQuate helps its clients achieve peak business health through artificial intelligent technology that integrates data and presents it as role-personalized insights and actionable workflows. (San Francisco). uses artificial intelligence-powered products to synchronize stroke care and improve access to life-saving therapies. It detects and alerts stroke teams and allows them to communicate in real time.

Wellframe (Boston). Wellframe uses AI technology and user data to generate real-time insights for care teams to improve health quality and outcomes.

Welltok (Denver). Welltok is a data-driven enterprise company that allows users to get actively involved in their health with the Consumer Activation Platform. It is a single platform for personalized health and wellbeing resources that powers growth and retention initiatives and improves healthcare value.

Woebot Labs (San Francisco). Woebot Labs aims to make mental health accessible to all with its Woebot application. It gives users daily lessons and check-ins and allows them to have conversations to think through situations and improve mental wellness.

Your.MD (London). Your.MD is a free mobile application that uses AI to give users health formation to help them make the best health choices.

Zebra (Lincolnshire, Ill.). Zebra’s products, software and services help healthcare professionals improve patient outcomes and business results by connecting them with assets and data.

Zephyr Health (Phoenix). Zephyr Health’s AI platform merges and analyzes public and private data sets for the Life Sciences industry. The company was acquired by Anju Software in 2018.

Zingbox (Mountain View, Calif.). Zingbox delivers am AI powered cloud-based platform which provides healthcare organizations with visibility, tracking, management and cybersecurity capabilities for the Internet of Things (IoT). The company’s comprehensive solution enables service providers in healthcare to deliver uninterrupted and secure critical care and service to patients and customers and gain organization-wide operational efficiencies.


Will Support Rapid Expansion of Vynca’s Advance Care Planning Solution

PALO ALTO, Calif., June 19, 2019 /PRNewswire/ — Vynca, the nation’s leading advance care planning solution, announced today that it has secured $10.3 million in Series B funding from First Trust Capital Partners, OCA Ventures, and Spectrum Health Ventures, in addition to key strategic individual investors. Current Vynca investors, including Generator Ventures and the Ziegler LinkAge Longevity Fund also participated. The funding will help fuel the company’s expansion into new geographies and drive new product development. Rachel Kern of First Trust Capital Partners, Phil Fogg Jr. of Marquis Companies, and Arnie E. Burchianti, II will join the Company’s Board of Directors. Dr. Scott Lancaster of Spectrum Health Ventures will join as a Board Observer.

Vynca’s end-to-end solution supports health care organizations to implement and scale high-quality advance care planning so that every person’s care preferences are honored at the end-of-life. Vynca technology supports education and engagement in advance care planning conversations, shared decision making, digital completion of documents, and ensures universal document accessibility for individuals, their caregivers, and health care providers across the care continuum.

“We’re pleased to receive the support and insight from these highly strategic health care investors who share our vision of creating a national advance care planning network,” stated Ryan Van Wert, M.D., co-founder and CEO of Vynca. “Our continued growth will ensure that more individuals have their voices heard, and that health care providers have immediate access to care preferences, so that every person’s end-of-life wishes are known and honored.”

Partnering with over 80 hospitals, as well as health plans, ACOs, and five state registries, Vynca clients are realizing an impact in terms of higher quality of care at the end-of-life and the avoidance of unwanted health care interventions.

“We are excited to partner with Vynca as the company continues to build on their position as the leading advance care planning solution,” said Rachel Kern of First Trust Capital Partners. “Vynca’s state registry partnerships and impressive growth are a testament to how they are setting a new standard for end-of-life care, ensuring that accurate care plans are available in critical moments. We look forward to being part of Vynca’s continued growth and success.”

“Spectrum Health Ventures supports innovations that can reduce cost, improve quality, and increase patient engagement and satisfaction,” said Scott Lancaster, M.D., clinical director for Spectrum Health Ventures. “We are proud to partner with Vynca, whose impressive growth and innovative platforms are providing national leadership by reflecting patient preferences for end-of-life care.”

CONTACT: Emelia Altschul, 914-260-1621,

Exclusive: Waze partners with SpotHero

SpotHero is integrating Waze, a navigation app owned by Google, into its app, Kia Kokalitcheva reports. Waze will navigate SpotHero’s customers to their pre-booked parking spots.

Why it matters: Americans spend 17 hours per year on average searching for parking, costing them $345 per driver in wasted time, fuel and emissions, according to INRIX. Both companies say they aim to help reduce congestion by helping cars get to their destinations more efficiently.

How it works: After users find and book a parking spot in SpotHero’s app, they hit a button for directions to that lot or garage. If they’re already Waze users, the app will open on their smartphone, preset to the destination, or they’ll be prompted to download Waze if they don’t already have it. A button will also let them toggle to their reservation ticket when they reach the garage.

  • Currently there’s no button inside the Waze app that guides its users to SpotHero’s app, though it’s something both companies hinted could be in the works for the future.
  • Adam Fried, head of Waze product partnerships, told Axios the company is thinking about helping users get to their final destinations once they’ve parked their vehicles, though he declined to share more details about its plans.

The deal doesn’t have a financial component, SpotHero CEO Mark Lawrence told Axios.

Go deeper: Kia has more here

The #PopHealth Show: Bob Saunders @ Oca Ventures – Health Innovation Focused

Join us today as we speak with Bob Saunders from Oca Ventures about health innovation focused.

Impossible Objects Unveils Next-Generation 3D Printer, Partners with BASF to Bring Industry-First Composite to 3D Printing

The CBAM-2 3D printing system delivers complex parts at production speeds and volumes, while partnership with BASF makes strong, heat-tolerant PA6-carbon fiber composite parts printable at scale

Impossible Objects’ new 3D printer, the CBAM-2, delivers complex parts on an industrial scale — speeding up the additive manufacturing process as much as 10x.

May 21, 2019 08:00 AM Eastern Daylight Time

DETROIT–(BUSINESS WIRE)–At RAPID + TCT 2019, Impossible Objects announced two watershed advances in composite 3D printing for the factory floor. The company’s latest 3D printing system, the CBAM-2, and a new partnership with BASF on PA6-carbon fiber composites extend Impossible Objects’ patented composite based additive manufacturing process (CBAM) to an unprecedented range of industrial applications.

“It’s been exciting to see how our customers are putting our approach to work to create high-performance parts for everything from aircraft and cars to lightweight athletic gear,” said Impossible Objects Founder and Chairman Bob Swartz. “We’re continuing to bring machines, materials and expertise to the market to transform the entire manufacturing process, from prototyping through to high-volume production.”

The CBAM-2 Speeds Production of 3D Parts at Scale

The new CBAM-2 3D printing system, being shown at RAPID + TCT for the first time, delivers complex parts on an industrial scale — speeding up the additive manufacturing process as much as 10x. The CBAM-2 combines high-performance polymers with long-fiber carbon and fiberglass sheets to rapidly produce 3D composite parts that are stronger, lighter, with better temperature performance, and more durable than possible with conventional 3D printing methods.

Since Impossible Objects launched its flagship Model One 3D printer at RAPID 2017, a growing number of Fortune 500 companies have adopted it. Major automotive manufacturers including Ford Motor Company, manufacturing services company Jabil, the United States Air Force, and the National Institute for Aviation Research (NIAR) among others are using Impossible Objects technology.

Features of the CBAM-2 include:

  • Production speed: The machine can produce high volumes of production parts quickly — up to 10x faster than conventional 3D printing.
  • Support for high-strength composites: The CBAM-2 can print 3D parts from composites that are not available through any other 3D printing method. Combining carbon fiber and fiberglass with high-performance thermoplastics like PEEK and Nylon can produce parts with better strength-to-weight ratios than metals, along with superior temperature performance and chemical resistance.
  • Support for larger parts: Printed sheets can now reach up to 12 inches x 12 inches in size.
  • Increased precision: The CBAM-2 features three added cameras, ensuring greater quality control and guaranteeing each sheet is printed perfectly and each inkjet nozzle is fired seamlessly.
  • Streamlined maintenance: Automatic powder filling reduces fill-time to days, and bulk ink cartridges eliminate the need to refill ink frequently, allowing machines to run efficiently at a significantly greater duration.

CBAM-2 machines will be available for customers beginning in Q3.

BASF Partnership: An Unmatched Range of Material Choices and Capabilities

Impossible Objects also announced that through a collaboration with BASF, its Model One and CBAM-2 printers will support BASF’s Ultrasint PA6 (polyamide 6) powder, allowing customers to 3D print high-performance carbon fiber-PA6 composite parts for the first time.

Carbon fiber-PA6 composites offer better strength and temperature performance at a lower cost than PA12, and are up to four times stronger than conventional Fused Deposition Modeling (FDM) parts and twice as strong as Multi Jet Fusion (MJF) parts made with PA12.

“Our collaboration with Impossible Objects opens up new possibilities for customers, especially in the automotive and industrial sectors where we’re seeing strong demand for PA6. This partnership is in line with our philosophy of open innovation and support for open platforms. We’re encouraged by how Impossible Objects is using PA6 and are excited to work together to advance the state of additive manufacturing,” said Kara Noack, regional business director for BASF 3D Printing Solutions.

“We’re honored to be collaborating with BASF 3D Printing Solutions to make this economical workhorse polymer, which is used in an enormous number of industrial applications, available to our customers,” added Bob Swartz of Impossible Objects.

PA6 adds to Impossible Objects’ currently supported materials and will be available for shipment in Q3. For information on the collaboration, please see this video.

Customer Momentum: Manufacturing parts for legacy aircraft with UAMMI

The Utah Advanced Materials & Manufacturing Initiative (UAMMI) announced the successful creation of its first carbon fiber 3D printed part for the United States Air Force, made with an Impossible Objects printer.

The 3D printed part, a first aid kit restraint strap for B-1 aircraft at Tinker Air Force Base in Oklahoma, is the first step in UAMMI’s mission to replace broken parts on legacy aircraft, whose original parts are no longer in production. For more information, please see UAMMI’s accompanying release.

Impossible Objects Secures Additional Funding

To meet the demand for its products, Impossible Objects has raised $4.1 million in funding in a round led by returning investor OCA Ventures, bringing total funding to more than $13 million. The company raised $6.4 million in Series A funding in October 2017 from OCA Ventures, IDEA Fund Partners, Mason Avenue Investments, Huizenga Capital Management, and Inflection Equity Partners.


  • Video about the CBAM manufacturing process.
  • Video about the BASF-Impossible Objects partnership.
  • Image of Impossible Objects CBAM-2.
  • Visit Impossible Objects at booth #403 at RAPID + TCT.

About Impossible Objects

Impossible Objects, a 3D printer and materials company, was founded with the belief that materials science inventions would enable 3D printing to revolutionize the world in the same ways that computers and the Internet have revolutionized the way we live, work and play. The company’s proprietary composite-based additive manufacturing (CBAM) technology produces parts up to 10 times faster than conventional 3D printing. By combining high-performance polymers like Nylon and PEEK with long-fiber carbon and fiberglass sheets, CBAM produces parts that are stronger, lighter, with better temperature performance, and more durable than possible with conventional 3D printing methods. For more information, visit


Molly Stein for Impossible Objects, 415-385-5137

Astarte Medical Secures $5 Million in Series A Financing to Advance its Technology for Improving Preterm Infant Outcomes

Company’s NICUtrition® suite of digital tools and diagnostics is designed to standardize feeding, optimize nutrition and quantify gut health in premature infants

NEWS PROVIDED BYAstarte Medical 

May 07, 2019, 08:31 ET

YARDLEY, Pa., May 7, 2019 /PRNewswire/ — Astarte Medical, the only precision medicine company using software and predictive analytics to improve premature infant outcomes, today announced it has secured $5 million in Series A financing. Investors in the round include Viking Global Investors LP, Lunsford Capital, OCA Ventures, Keiretsu Forum MidAtlantic, Keiretsu Capital Fund, Ben Franklin Technology Partners, Wing VC and Next Act Fund. The Company, which recently graduated from the Illumina Accelerator, will use the funds to complete the development of its NICUtrition® suite of digital tools and diagnostics, which support feeding protocols, practice and decision-making in the neonatal ICU (NICU). Duane Morris LLP, as legal council to Astarte Medical, advised the company on the transaction.

Every year, more than 380,000 babies are born prematurely in the United States. The first 1,000 days of life are a critical period for a baby’s growth and brain development – particularly for preterm infants – and maintaining a healthy gut is crucial during this time. The rapid changes in the microbiome during this period make it challenging for NICU teams to treat infants with a highly personalized level of care.

“This funding will bring us one step closer to completing our suite of solutions to support unmet needs in the NICU to drive better preterm infant outcomes such as improved growth and minimized risk of infection,” said Tracy Warren, CEO and Co-founder, Astarte Medical. “NICU feeding protocols are complex and often tracked manually, causing clinical care teams to spend unnecessary time on documentation. Our first product to market will automate and streamline feeding protocols, enabling doctors and nurses to spend more time with their patients and parents.”

Core to Astarte Medical’s platform is its comprehensive and proprietary dataset that integrates feeding protocols, microbial profiles and clinical information. Its NICUtrition® suite of products provides actionable information in real time to hospitals and clinical teams, enabling them to standardize care protocols, and customize treatment plans by quantifying preterm infant gut health.

“We are thrilled to support Astarte Medical as they develop cutting-edge technology to solve some of the biggest problems for the smallest patients,” said Bruce Lunsford, Chairman and CEO of Lunsford Capital. “With its first solution, the Company is poised to make a difference for not just the preterm babies, but also for clinical teams in NICUs where it will help streamline the workflow and increase efficiencies. Astarte Medical is addressing the needs of a large and underserved market, and we look forward to seeing the Company positively impact the industry, lowering healthcare costs and improving health for generations to come.”

Astarte Medical is comprised of a passionate management team and world-class advisors in neonatology, microbiome and predictive analytics. Company founders, Tracy Warren and Tammi Jantzen, have worked together for nearly twenty years as investors and serial entrepreneurs. Together, they are applying their expertise and business acumen to the vision of Katherine Gregory, PhD, RN, the company’s scientific co-founder. A NICU nurse by background, Dr. Gregory integrates her clinical experience with translational research, focused on preterm infant gut health and nutrition. She currently serves as Associate Chief Nursing Officer, Women’s and Newborn Health, Brigham and Women’s Hospital and Assistant Professor of Pediatrics, Harvard Medical School.       

Astarte Medical recently appointed Eric Heil and Stephen Hanson to its Board of Directors. Heil is an executive with extensive early stage, venture-backed entrepreneurial experience in healthcare, and currently teaches healthcare entrepreneurship at University of Pennsylvania’s Wharton School of Business. Hanson is an accomplished hospital leader who has optimized performance for five health systems and four independent hospitals in seven states. Together, they will bring strategic oversight to Asarte Medical’s roadmap of solutions to improve preterm infant outcomes.

About Astarte Medical 
Astarte Medical is the only precision medicine company using software and predictive analytics to improve outcomes during the first 1,000 days of life, with an initial focus on preterm infants. NICUtrition® by Astarte Medical supports feeding protocols, practice and decision-making in the neonatal ICU with a suite of digital tools and diagnostics designed to standardize feeding, optimize nutrition and quantify gut health. Learn more at

This project is supported by the Ben Franklin Technology Partners of Southeastern PA, an initiative of the Pennsylvania Department of Community and Economic Development funded by the Ben Franklin Technology Development Authority.

Media Contact
Alyson Kuritz

Custom Ink Welcomes New Investors Led by Great Hill Partners

FAIRFAX, Va. & BOSTON–(BUSINESS WIRE)–Apr 4, 2019–Custom Ink, the leader in custom apparel for groups, companies, and communities, today announced it has entered into a definitive agreement with an investor group led by Great Hill Partners, a leading growth-oriented private equity firm, to recapitalize the company for its next chapter of growth and innovation. Custom Ink’s current management team will continue to lead the company, with Co-founder Marc Katz remaining a major shareholder as well as Chairman & CEO. Custom Ink’s current shareholders, including Revolution Growth and SWaN & Legend Venture Partners, will exit their investments. Financial terms of the private transaction were not disclosed.

This press release features multimedia. View the full release here:

Founded in 2000, Custom Ink helps people create a sense of belonging and community within their schools, teams, businesses, charities, and other groups through digitally-powered solutions for the design, ordering, production, and delivery of customized apparel and other products. The company’s strong brand, robust platform, and caring and capable team have made it the leader in the custom apparel market with projected 2019 revenues exceeding $400 million. Custom Ink’s core values – The Golden Rule, Ownership and Innovation – and purpose-driven culture have earned it a perennial place on local and national “best places to work” lists and fueled industry-leading customer satisfaction and employee engagement.

“This is a really important milestone for Custom Ink,” said Katz. “It’s a testament to the great work of our team over the past 19 years, and it positions us well for the future. Our early investors were friends, family, and angels who saw the potential in Custom Ink, and more recent investors provided expertise and support to accelerate our growth. Now they are passing the baton to our new partners, who also embrace our values and vision. Great Hill in particular has an outstanding track-record of enhancing ecommerce and direct-to-customer companies that are similarly passionate about marketplace and workplace excellence. I think they’re an ideal partner to help us continue to build out our unique brand, offering, and platform.”

Great Hill Partners has deep experience investing in highly differentiated business models across the consumer, e-commerce, and retail sectors. The firm has a long history of backing native digital and omni-channel brands, such as Wayfair, Bombas, The RealReal, and The Shade Store.

“Custom Ink helped pioneer online customization and has created the industry’s leading end-to-end digitally-powered platform for customized apparel,” said Michael Kumin, a Managing Partner at Great Hill Partners. “This is a terrific brand with outstanding operations in a highly-fragmented category where we see huge growth potential for the company. We’re thrilled to back Marc and the team and are excited to help Custom Ink extend its market leadership, both organically and inorganically.”

Ted Leonsis, co-founder and partner at Revolution Growth, said, “When Revolution first invested in Custom Ink in 2013, we were impressed with how the company was using technology, combined with a passion for service, to revolutionize the custom apparel category and bring people together. We saw power in Custom Ink’s community-driven growth model, and this has proven to be a very successful investment. We’re proud of our role at Custom Ink and think Great Hill will be an excellent partner for the company’s next stage.”

Fred Schaufeld, SWaN co-founder and partner and longtime Custom Ink adviser, will remain an investor and board member in a personal capacity. Said Schaufeld, “Custom Ink is a wonderful story of creativity, determination, and striving to do the right thing. This was an excellent outcome for SWaN, and I couldn’t be more excited for Marc and the team. It’s a great company that will continue to do great things.”

The transaction is expected to close in May. Investing alongside Great Hill is HarbourVest Partners, a global private markets asset manager. GSO Capital Partners is providing committed debt financing as well as an equity investment in connection with the transaction. Guggenheim Securities LLC and DLA Piper advised Custom Ink on financial and legal matters, respectively.

About Custom Ink

Custom Ink is the leader in custom apparel and accessories for groups, events, and special occasions. The company helps group organizers bring their families, friends, teammates, and colleagues together with inspired designs they are proud to wear. Custom Ink makes the customization process fun and easy with innovative design tools, caring customer service, creative design inspiration and high-quality merchandise. It also offers Custom Ink Fundraising, a platform to raise money and awareness for charities and personal causes through the sale of custom t-shirts. Its influencer-led custom apparel platform, Represent, helps actors, athletes, musicians, thought leaders, and social media icons create and sell limited-run t-shirts and merchandise to their fans. Custom Ink is based in Fairfax, Virginia with other locations that include Charlottesville, Virginia; Reno, Nevada; Dallas, Texas; and Los Angeles, California.

About Great Hill Partners

Great Hill Partners is a private equity firm that has raised over $5 billion in commitments since inception to finance the expansion, recapitalization, or acquisition of growth companies in a wide range of sectors in business-to-consumer and business-to-business industries including eCommerce, software, financial and healthcare technology, digital media and internet infrastructure. For more information, visit

About HarbourVest

HarbourVest is an independent, global private markets asset manager with more than 36 years of experience and more than $58 billion in assets under management. The Firm’s powerful global platform offers clients investment opportunities through primary fund investments, secondary investments, and direct co-investments in commingled funds or separately managed accounts. HarbourVest has more than 500 employees, including more than 100 investment professionals across Asia, Europe, and the Americas. This global team has committed more than $35 billion to newly-formed funds, completed over $19 billion in secondary purchases, and invested over $9 billion directly in operating companies. Partnering with HarbourVest, clients have access to customized solutions, longstanding relationships, actionable insights, and proven results.

View source version on

CONTACT: For Custom Ink:

Andrew Weinstein

Ridgeback Communications


For Great Hill Partners:

Charlyn Lusk

Stanton Public Relations




SOURCE: Great Hill Partners

Copyright Business Wire 2019.

PUB: 04/04/2019 07:00 AM/DISC: 04/04/2019 07:00 AM

Startup Matching Foreign Med Students With U.S. Rotations Raises $2.2M

A Chicago startup with ties to the University of Chicago that provides international medical students and graduates with clinical training at U.S. healthcare systems just raised a new round of funding.

AMOpportunities announced Monday that it has raised $2.2 million from investors, such as OCA Ventures, HealthX Ventures, Wildcat and M25 Group. The University of Chicago also invested.

The new funding brings AMOpportunities’ total funding to nearly $3.3 million.

The startup says it will use the new financing to scale its clinical visitor platform, which will be designed for use by U.S. hospitals and foreign medical schools.

Founded in 2013 by Kyle Swinsky and Benjamin Bradley, AMOpportunities makes a platform that allows medical students to find month-long clinical rotations at U.S. healthcare systems that match with their specialty and experience level. AMOpportunities makes money from fees it charges students for available rotations.

Participating in rotation programs in the U.S. is required before foreign-educated doctors can practice in the U.S.

“To thrive, the American healthcare system needs doctors from all over the world,” Swinsky said in a statement. “Without these international trainees, the U.S. will experience a devastating physician shortage. We need these international physicians to ensure our healthcare system survives. Diversity and immigration will only make our country stronger.”

AMOpportunities, which won the 2017 University of Chicago New Venture Challenge, has hosted more than 2,500 visitors across over 200 clinical sites in the U.S. since launching. The startup now has affiliations and partnerships with health systems, such as the University of Illinois Chicago, University of Miami and Saint Anthony Hospital.